Did you know that about 40% of people with HIV face brain problems called neurocognitive impairment (NCI)? This issue can mess up their daily lives, make it tough to stick to their HIV meds, and even shorten their lifespan. Many things can cause NCI in HIV patients, like taking the wrong meds, getti
Cryptococcal meningitis is a big problem for people with HIV, especially when the fungus Cryptococcus neoformans gets into their brain. Researchers in Libreville, Gabon, wanted to find out how common it is for HIV patients with neurological symptoms to have Cryptococcus antigen in their urine. They
You might think that exercising is the last thing on the mind of older people living with HIV. But did you know that less than half of these folks meet the recommended exercise levels? A recent study aimed to understand what drives older, sedentary people with HIV to join exercise trials. Researcher
In the bustling city of Cape Town, many young women who have left school are facing a daunting set of challenges. A new study delved into the surprising connections between these girls' actions and their potentially dangerous decisions. Researchers sat down with 500 young women to chat about their b
In the world of HIV and health, researchers have been busy finding out how common it is for people living with HIV to have oral HPV infections. They also wanted to figure out what makes some people more likely to get this infection. The study team talked to 66 people with HIV, asking about their liv
Have you ever wondered how different HIV treatments work for older adults? A study took a close look at how well dolutegravir-based regimens stack up against others like raltegravir-, elvitegravir-, bictegravir-, and darunavir-based regimens. This study involved older veterans living with HIV and ai
In Uganda, HIV prevention is a major concern, especially among young females. A study at a public university aimed to uncover what might influence female students' willingness to use a long-acting HIV prevention drug called Cabotegravir (CAB-LA). This drug is injected every two months, making it a c
In the heart of Tanzania, there's a story unfolding about adolescents living with HIV (ALHIV). These teens face a significant challenge: they're not sticking to their treatment plans. This can lead to poor health outcomes, all because they're struggling to follow their medication routines. Why is t
These days, mobile health or mHealth technologies are super popular. But guess what? We don't know much about how these apps and tools help people with HIV who also deal with substance use disorders. The big question is: Which mHealth system features can really make a difference in keeping these fol
In January 2024, Tanzania began using a 12-dose weekly regimen of isoniazid and rifapentine (3HP) to prevent TB in people with HIV. This medicine can be taken for just 12 weeks instead of the usual 9 months. A study was done before the start of this program to see if a support system involving famil
